San Raffaele Hospital is one of the top centers of Gruppo San Donato (Italy’s largest hospital group, treating over 4.7 million patients yearly). San Raffaele University & Research Hospital is an institute that incorporates clinical, research and university activities altogether, while being internationally recognized for its specialization in some of the most complex pathologies. The hospital is a multi-specialty center with more than 50 clinical specialties covered and over 1300 beds, which is accredited by the Italian National Health System to provide treatment to both public and private, national and international patients. In 2016, the San Raffaele Hospital performed nearly 51,000 patient admissions, 67,700 emergency room interventions and delivered over 7 million healthcare services, including outpatient appointments and diagnostic exams. It is considered to be the most famous hospital in the country and among the most reputable medical centers in Europe.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Headquartered in San Diego, California, Pfēnex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfēnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfēnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.

Lysando AG is a private company headquartered in Liechtenstein. The firm provides research and development services to the life science pharmaceuticals.\nThe company says this about itself: Lysando AG with subsidiaries in Regensburg and Bangkok was founded in Liechtenstein in 2009. Lysando AG is focused on the development of its proprietary Artilysin(R) platform to become the world's leading antimicrobial technology. Artilysin(R) technology has already been successfully established in the fields of medical devices and veterinary medicine. With licensing Artilysin(R) to AiCuris, the technology has now gained a foothold in the field of human pharmaceutics.The Artilysin(R) technology is effective against all germs classified as particularly dangerous by the WHO. Artilysin(R) is resistance breaking, environmentally friendly and gently to the microbiome. As of today, Lysando AG has granted over a dozen licenses to global companies.

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

Tianjin Qiren Pharmaceutical Technology Co., Ltd., established on 2008-12-08, Business scope includes technical development of biomedical related products,Serve,transfer;Machinery sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Angyitai Geological Microbial Technology (Beijing) Co., Ltd., established on 2007-01-12, Business scope includes oil and gas exploration,Technology development for mining and biotechnology,Technical Services,technology transfer,Technology Promotion,technical consulting;software development;sales software,Minerals;Import and export,Technology Import and Export,Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Tianjin Century Wellcome Biotechnology Co., Ltd., established on 2017-03-24, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Food Additive Sales;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Food import and export;food sales(Only sell prepackaged food);Production of protective equipment for medical personnel(Ι class medical device);Fermentation process optimization technology research and development;Import and export;Cosmetics Wholesale;Cosmetics Retail;Wholesale medical masks;Medical Mask Retail;Retailing of protective equipment for healthcare workers.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Food additive production;food production;beverage production;dairy production;Food Internet Sales;Production of formula food for special medical purpose.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

MicroBioPharm Japan Co. Ltd. manufactures pharmaceutical drugs and chemicals, and drug discovery business. It products include Anthracycline analogues, Macrolide analogue, Calcitriol, Paricalcitol and Cyclodextrins. The firm offers toll fermentation, contract research, seed discovery support and drug discovery support services. It partners with pharmaceuticals companies and external research institutes. The company was founded on July 1, 2011 and is headquartered in Tokyo, Japan.

Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Mercian Corporation is a Tokyo-based operating unit of Kirin, primarily engaged in the production and retail of wine and other alcoholic beverages. Chateau Mercian, produced and sold in Japan, is one of the most widely available brands of Japanese wine. Mercian Corporation also markets imported wine such as Casillero del Diablo, Frontera, and Sunrise brands in partnership with Concha y Toro, a leading Chilean wine producer.

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

The Lee Co. supplies precision fluid control products to industries including aerospace, formula 1 racing, oil exploration, automotive and off-highway equipment, and medical and scientific instruments. Its products include precision microhydraulics and electro-fluidic systems. The company was founded by Leighton Lee II in 1948 and is headquartered in Westbrook, CT.

AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

New England Biolabs is focused on the discovery and development of recombinant and native enzymes for genomic research. It offers restriction endonucleases for DNA digestion; PCR, polymerases, and amplification technologies for PCR applications; DNA modifying enzymes and cloning technologies; reagents for DNA and RNA sample preparation; DNA, RNA, and protein markers and ladders for electrophoresis applications; reagents for RNA research; and gene expression tools for DNA, RNA, and protein transfection of cell lines. The company also offers cellular analysis solutions; reagents, enzymes, antibodies, and DNA controls for epigenetics research; protein expression and purification technologies; competent cells for transformation and protein expression; protein tools; glycobiology products; and plasmids and DNAs for use in cloning experiments. New England Biolabs was founded in 1974 and is based in Ipswich, Massachusetts.